Brokerages Set Humacyte, Inc. (NASDAQ:HUMA) Price Target at $13.71
Shares of Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) have earned an average recommendation of “Buy” from the eight ratings firms that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to […]
Shares of Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) have earned an average recommendation of “Buy” from the eight ratings firms that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to […]
